Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
348 | 16958 | 49.3 | 88% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
96 | 73697 | DNA METHYLATION//FRAGILE X SYNDROME//RETT SYNDROME |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DNA METHYLATION | Author keyword | 1004 | 32% | 15% | 2595 |
2 | EPIGENETICS | Author keyword | 421 | 22% | 10% | 1658 |
3 | HISTONE DEACETYLASE INHIBITOR | Author keyword | 348 | 56% | 2% | 422 |
4 | HISTONE DEACETYLASE INHIBITORS | Author keyword | 258 | 57% | 2% | 304 |
5 | HISTONE DEACETYLASE | Author keyword | 256 | 40% | 3% | 495 |
6 | HDAC INHIBITOR | Author keyword | 180 | 56% | 1% | 221 |
7 | DNA METHYLTRANSFERASE | Author keyword | 138 | 45% | 1% | 233 |
8 | METHYLATION | Author keyword | 137 | 15% | 5% | 855 |
9 | RASSF1A | Author keyword | 130 | 62% | 1% | 136 |
10 | 5 HYDROXYMETHYLCYTOSINE | Author keyword | 127 | 73% | 1% | 97 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DNA METHYLATION | 1004 | 32% | 15% | 2595 | Search DNA+METHYLATION | Search DNA+METHYLATION |
2 | EPIGENETICS | 421 | 22% | 10% | 1658 | Search EPIGENETICS | Search EPIGENETICS |
3 | HISTONE DEACETYLASE INHIBITOR | 348 | 56% | 2% | 422 | Search HISTONE+DEACETYLASE+INHIBITOR | Search HISTONE+DEACETYLASE+INHIBITOR |
4 | HISTONE DEACETYLASE INHIBITORS | 258 | 57% | 2% | 304 | Search HISTONE+DEACETYLASE+INHIBITORS | Search HISTONE+DEACETYLASE+INHIBITORS |
5 | HISTONE DEACETYLASE | 256 | 40% | 3% | 495 | Search HISTONE+DEACETYLASE | Search HISTONE+DEACETYLASE |
6 | HDAC INHIBITOR | 180 | 56% | 1% | 221 | Search HDAC+INHIBITOR | Search HDAC+INHIBITOR |
7 | DNA METHYLTRANSFERASE | 138 | 45% | 1% | 233 | Search DNA+METHYLTRANSFERASE | Search DNA+METHYLTRANSFERASE |
8 | METHYLATION | 137 | 15% | 5% | 855 | Search METHYLATION | Search METHYLATION |
9 | RASSF1A | 130 | 62% | 1% | 136 | Search RASSF1A | Search RASSF1A |
10 | 5 HYDROXYMETHYLCYTOSINE | 127 | 73% | 1% | 97 | Search 5+HYDROXYMETHYLCYTOSINE | Search 5+HYDROXYMETHYLCYTOSINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SUBEROYLANILIDE HYDROXAMIC ACID | 802 | 65% | 4% | 762 |
2 | DNA METHYLATION | 612 | 18% | 18% | 3015 |
3 | 5 HYDROXYMETHYLCYTOSINE | 482 | 73% | 2% | 368 |
4 | 5 METHYLCYTOSINE | 453 | 59% | 3% | 513 |
5 | HISTONE DEACETYLASE INHIBITORS | 397 | 32% | 6% | 1044 |
6 | HDAC INHIBITORS | 391 | 65% | 2% | 369 |
7 | HYPERMETHYLATION | 374 | 30% | 6% | 1050 |
8 | DE NOVO METHYLATION | 369 | 51% | 3% | 523 |
9 | TRICHOSTATIN A | 343 | 50% | 3% | 500 |
10 | MAMMALIAN DNA | 291 | 66% | 2% | 267 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EPIGENETICS | 142 | 34% | 2% | 338 |
2 | EPIGENOMICS | 77 | 44% | 1% | 132 |
3 | CLINICAL EPIGENETICS | 39 | 41% | 0% | 74 |
4 | EPIGENETICS & CHROMATIN | 6 | 17% | 0% | 34 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Function and information content of DNA methylation | 2015 | 26 | 115 | 69% |
Functions of DNA methylation: islands, start sites, gene bodies and beyond | 2012 | 627 | 96 | 65% |
Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions | 2014 | 104 | 209 | 77% |
New and emerging HDAC inhibitors for cancer treatment | 2014 | 90 | 123 | 76% |
Epigenetics and human obesity | 2015 | 11 | 111 | 72% |
Anticancer activities of histone deacetylase inhibitors | 2006 | 1390 | 198 | 73% |
DNA methylation: roles in mammalian development | 2013 | 277 | 196 | 48% |
TET enzymes, TDG and the dynamics of DNA demethylation | 2013 | 148 | 99 | 82% |
Molecular origins of cancer: Epigenetics in cancer | 2008 | 1320 | 91 | 44% |
The fundamental role of epigenetic events in cancer | 2002 | 2978 | 107 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EPIGENET | 62 | 29% | 1.1% | 183 |
2 | CANC EPIGENET | 42 | 30% | 0.7% | 117 |
3 | EPIGENET GENE REGULAT CANC SECT | 38 | 93% | 0.1% | 14 |
4 | SACKLER PROGRAM EPIGENET DEV PSYCHOBIOL | 38 | 86% | 0.1% | 19 |
5 | KREMBIL FAMILY EPIGENET | 20 | 63% | 0.1% | 20 |
6 | STAT GENOM GRP | 19 | 71% | 0.1% | 15 |
7 | AG TUMORGENET MED FAK | 18 | 89% | 0.0% | 8 |
8 | EXCELLENCE MOL GENET CANC HUMAN DIS | 17 | 49% | 0.1% | 25 |
9 | ENVIRONM EPIGENET | 16 | 56% | 0.1% | 19 |
10 | GRP EPIGENET | 15 | 67% | 0.1% | 14 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000025846 | GENOMIC IMPRINTING//H19//BECKWITH WIEDEMANN SYNDROME |
2 | 0.0000024380 | PROTEIN KINASE D//PROTEIN KINASE D PKD//MEF2C |
3 | 0.0000018188 | XIST//X CHROMOSOME INACTIVATION//TSIX |
4 | 0.0000011853 | CHROMATIN//EZH2//NUCLEOSOME |
5 | 0.0000010595 | RETT SYNDROME//MECP2//MECP2 GENE |
6 | 0.0000008841 | MASPIN//RARRES3//TIG3 |
7 | 0.0000007816 | SIRT1//SIRTUIN//FOXM1 |
8 | 0.0000006724 | HUMAN ENDOGENOUS RETROVIRUS//ADAR//ENDOGENOUS RETROVIRUS |
9 | 0.0000006600 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//HNPCC |
10 | 0.0000006474 | BRANCHIO OCULO FACIAL SYNDROME//RIZ1//BCL6 |